PECAM1 and infarction: Compared to the PBS-injected group, MSC injection markedly increased the number of CD31-positive cells, as well as blood vessel density in infarcted hearts 5 days after infarction (17.75±2.6 VS 8.60±1.5/HPF, P<0.01, Fig 2A and 2B).